News Medical on MSN3h
A novel synthetic lethal target for ATM inhibitors in pancreatic cancerA novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 ...
Along with defending against pathogens, the body's innate immune system helps to protect the stability of our genomes in unexpected ways -- ways that have important implications for the development of ...
PharmaJet Poster Presentation at Cancer Immunotherapy Conference Highlights How Needle-free Technology is Enhancing Oncology ...
A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 as a potential synthetic ...
Live Science on MSN13h
BRCA only explains a fraction of breast cancers — genes tied to metabolism may also up riskScientists pinpointed 80 gene variants, including eight tied to fatty acid metabolism, that may cause breast cancer in some ...
Six/UW/Seattle Children’s Cancer Consortium scientists received new funding from the Breast Cancer Research Foundation to ...
Personalized medicine is changing healthcare by creating treatments specifically designed for each person. And when it comes to leading this new approach, Boston is making huge contributions. As one ...
Results from OVATION 2 Study of IMNN-001 to be highlighted in late-breaking acceptanceCompany also announces FDA End-of-Phase 2 in-person meeting ...
The outline of this labyrinthine cellular machinery, the most complex in humans, opens up new ways of designing treatments against a multitude of diseases ...
UC Irvine Researchers Innovate Enzyme Production for Synthetic Genetic Material in Disease Treatment
A research team led by the University of California, Irvine has engineered an efficient new enzyme that can produce a ...
Cancer cells can evade the immune system, create their own blood supply, and adapt to survive under different conditions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback